K Tomany, MD
Orthopaedic Surgery · N Chelmsford, MANPI 1790746675
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,158 of the $1,740 with a category attached, or 66.6%. 16 manufacturers reported payments, led by Kairos Surgical Inc at 33.4% of the total. Reporting peaked in 2020 at $599 and has fallen 56.2% since, to $263 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in MA, where the typical reported total is $3,637.
Across 44 payments — averaging $39.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kairos Surgical Inc$581
- Acumed LLC$172
- Stryker$152
- Vertex$138
- Bioventus LLC$129
- Johnson & Johnson$128
- plus $438 from 10 others
What the payments were for
- Food & beverage$1,15867%
- Education$58133%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kairos Surgical Inc | 1 | $581 |
| Acumed LLC | 5 | $172 |
| Stryker | 3 | $152 |
| Vertex | 7 | $138 |
| Bioventus LLC | 6 | $129 |
| Johnson & Johnson | 5 | $128 |
| Radius Health, Inc. | 3 | $106 |
| Endo Pharmaceuticals Inc. | 4 | $94 |
| Orthofix Medical, Inc. | 3 | $53 |
| Pacira Pharmaceuticals Incorporated | 1 | $42 |
| Polynovo North America LLC | 1 | $34 |
| Zimmer Biomet | 1 | $32 |
| Sanara Medtech Inc. | 1 | $22 |
| DJO, LLC | 1 | $22 |
| Endo USA, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
How this compares
$1,740 in reported general payments places this provider in the 35th percentile of 542 orthopaedic surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 16 | $208 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 61 | $190 |
| Methylprednisolone | 31 | $170 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $155 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $94 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in N Chelmsford
- Paul TornettaBoston$16.3M
- Thomas ThornhillBoston$12M
- Stephen MurphyRoxbury Crossing$8M
- Andrew FreibergBoston$5.9M
- Jon WarnerBoston$5.4M
- Wolfgang FitzBoston$3.7M
- Brian KwonWaltham$1.9M
- Simon ChaoNorth Easton$1.6M
- Scott SigmanNorth Chelmsford$1.4M
- Michael LangworthyNorth Dartmouth$715K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.